XML 79 R65.htm IDEA: XBRL DOCUMENT v3.25.3
SHARE-BASED PAYMENTS - Schedule of Share-based Compensation, Stock Options, Activity (Details)
$ / shares in Units, $ in Thousands
 9 Months Ended
Sep. 30, 2025
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Number of options, beginning of period (in shares) | shares 1,132,972
Number of grants in period, net of forfeitures (in shares) | shares 2,020,825
Number of forfeitures in period (in shares) | shares (128,415)
Number of expirations in period (in shares) | shares (39,515)
Number of options, end of period (in shares) | shares 2,746,257
Number of exercisable options (in shares) | shares 436,788
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Weighted average exercise price, beginning of period (in dollars per share) $ 6.58
Grants in period, weighted average exercise price (in dollars per share) 6.00
Exercises in period, weighted average exercise price (in dollars per share) 4.54
Forfeitures in period, weighted average exercise price (in dollars per share) 5.88
Expirations in period, weighted average exercise price (in dollars per share) 3.14
Weighted average exercise price, end of period (in dollars per share) $ 6.42
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 3 years 10 months 17 days
Exercisable options, weighted average remaining contractual term 2 years 10 months 20 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | $ $ 24,538
Exercisable options, weighted average exercise price (in dollars per share) $ 7.21
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | $ $ 3,557
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Number of shares, exercises in period (in shares) | shares (239,610)
Minimum  
Range of Exercise Prices  
Outstanding (in dollars per share) $ 1.76
Expired (in dollars per share) 1.76
Granted (in dollars per share) 4.57
Exercised (in dollars per share) 1.76
Forfeited (in dollars per share) 5.43
Exercisable (in dollars per share) 2.92
Outstanding (in dollars per share) 2.92
Maximum  
Range of Exercise Prices  
Outstanding (in dollars per share) 8.60
Expired (in dollars per share) 7.48
Granted (in dollars per share) 10.69
Exercised (in dollars per share) 8.41
Forfeited (in dollars per share) 7.48
Exercisable (in dollars per share) 8.60
Outstanding (in dollars per share) $ 10.69
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Exercisable options, weighted average remaining contractual term 10 years
Equity Option  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]  
Number of nonvested shares, beginning of period (in shares) | shares 798,803
Granted, nonvested, number of shares (in shares) | shares 2,020,825
Vested, number of shares (in shares) | shares (381,745)
Nonvested options forfeited, number of shares (in shares) | shares (128,415)
Number of nonvested shares, end of period (in shares) | shares 2,309,468
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share) $ 3.35
Granted, nonvested, weighted average grant date fair value (in dollars per share) 2.30
Vested, weighted average grant date fair value (in dollars per share) 3.43
Nonvested options forfeited, weighted average grant date fair value (in dollars per share) 2.47
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 2.47